February 21, 2007 – InSightec’s ExAblate 2000, a Magnetic Resonance Imaging (MRI) focused ultrasound device that treats uterine fibroid tumors, is now allowing most patients to find relief within three months of treatment and to return to work within days.
The ExAblate 2000 uses a combination of ultrasound waves and MRIs to image, treat and ablate soft tissue. Treatment typically takes about three or four hours.
April 17, 2024 — VISTA.AI announced the appointment of Daniel Hawkins as President and CEO. The company is pioneering AI ...
April 17, 2024 
April 8, 2024 — Magnetic resonance-guided focused ultrasound (MRgFUS) is a non-invasive technique for neuroregulation ...
April 08, 2024 
April 4, 2024 — FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging ...
April 04, 2024 
April 2, 2024 — In a 10-center study, microwave ablation offered progression free survival rates and fewer complications ...
April 02, 2024 
March 29, 2024 — Magnetic resonance imaging (MRI) is a cornerstone in the landscape of medical diagnostics, celebrated ...
March 29, 2024 
March 27, 2024 — SyntheticMR announced that its next-generation imaging solution, SyMRI 3D, has received FDA 510(k) ...
March 27, 2024 
March 21, 2024 — Artificial intelligence can spot COVID-19 in lung ultrasound images much like facial recognition ...
March 21, 2024 
March 1, 2024 — Royal Philips, a global leader in health technology, and magnetic resonance imaging (MRI) software ...
March 01, 2024 
February 13, 2024 — Butterfly Network, Inc., a digital health company transforming care through the power of portable ...
February 13, 2024 
February 12, 2024 — According to the American Journal of Roentgenology (AJR), free-breathing cine-deep learning (DL) may ...
February 12, 2024